The NTD treatment market is anticipated to grow at a more than CAGR of 8% during the forecast period. NTDs are a diverse group of parasitic and bacterial diseases that cause prevail in tropical and subtropical conditions. Some of the NTD is communicable in nature also. According to the World Health Organization (WHO), NTDs prevalence is in approximately 149 countries affecting more than one billion people across the globe.

Raising awareness regarding various NTD in emerging economies, increasing individual disposable income, development of new drugs and vaccines are driving the NTD treatment market during the forecast period. Moreover, the implementation of various appropriate measures and policies by the government and global health organizations for NTD elimination is contributing significantly to the NTD treatment market. For instance, WHO’s NTD Roadmap is an initiative working on NTD for the elimination and the eradication of at least two NTD by 2020. However, the underdeveloped health care sector is presenting restraint to the growth of the NTD treatment market in the emerging economies during the forecast period.

Free Sample Copy @ https://www.omrglobal.com/request-sample/ntd-treatment-market

The global NTD treatment market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is anticipated to hold the major market share with a significant growth rate owing to the raising initiatives to eliminate NTD across the countries. For instance, since 2013, the Organisation of Pharmaceutical Producers of India (OPPI) in collaboration with Global Health Progress (GHP) and International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) are working on the elimination of NTD in India. Moreover, the presence of a huge target population in Asian countries will also contribute to the growth of the NTD treatment market.

Besides, the Rest of the world that consists of Latin America and the Middle East & African countries is expected also expected to showcase a significant growth rate in the NTD treatment market. The burden of NTD diseases is increasing significantly across these countries. Additionally, raising awareness of NTD treatment coupled with the surge in various initiatives by global health organizations in the region will also aid in the growth of the NTD treatment Market.

A Full Report of Global NTD Treatment Market is Available at:
https://www.omrglobal.com/industry-reports/ntd-treatment-market

The global NTD treatment market is segmented based on disease and treatment. Based on the disease, the market is sub-segmented into dengue, rabies, trachoma, Buruli ulcer, leprosy, Chagas disease, and others. Further, based on the treatment, the market is bifurcated into drugs and vaccines. On the basis of end-user, the market is bifurcated into public and individual.

Global NTD Treatment Market – Segmentation
by Disease
Dengue
Rabies
Trachoma
Buruli ulcer
Leprosy
Chagas disease
Others
by Treatment
Drugs
Vaccines
by End-User
Government/ Public
Individual

Global NTD Treatment Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
AbbVie Inc.
Astellas Pharma Inc.
Bayer AG
CadilaHealthcare Ltd.
Daiichi Sankyo Company, Ltd.
Eisai Co., Ltd.
Eli Lilly & Co.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Humanigen, Inc.
Insud Pharma S.L.U.
Merck KGaA
Novartis AG
Oblita Therapeutics
Pfizer Inc.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Ltd.
Teva Pharmaceutical Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ntd-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404